ACE2 and COVID-19: Importantly, we found that co-stimulation with CR Abs and RBD triggered NETosis via the SFK/PI3K/PAD4 signaling pathway, and our results suggest that blocking neutrophil activation by ACE2 or dasatinib may be a potential therapeutic strategy to prevent NETosis-induced immunothrombosis in COVID-19.